"the drug must be administered at the right time point during development," he said.
.
.
.the total amount paid out in critical illness claims was £75.19m, with cancer accounting for 74 per cent of claims from women, mainly breast cancer, alongside 51 per cent from men.
.
. why novartis� landmark cancer drug approval is great news for bluebird
.